Robyn Jacobs, MD
Nephrology · St Louis, MONPI 1730288317
Payments from drug & device makers
Across 9 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$31
- Calliditas Therapeutics US Inc.$24
- Vifor Pharma, Inc.$21
- Ardelyx, Inc.$20
- Vantive US Healthcare LLC$20
- Baxter Healthcare$18
- plus $9 from 1 others
What the payments were for
- Food & beverage$13494%
- Education$96%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
| Vantive US Healthcare LLC | 1 | $20 |
| Baxter Healthcare | 1 | $18 |
| Travere Therapeutics, Inc. | 3 | $9 |
How this compares
$143 in reported general payments places this provider in the 15th percentile of 253 nephrology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VeltassaPatiromer Calcium Sorbitex | 52 | $53,316 |
| LokelmaSodium Zirconium Cyclosilicate | 62 | $48,074 |
| ZenpepLipase/Protease/Amylase | 12 | $45,981 |
| XphozahTenapanor Hcl | 12 | $36,018 |
| Sevelamer Carbonate | 63 | $11,767 |
| Clonidine | 107 | $11,122 |
| FarxigaDapagliflozin Propanediol | 14 | $8,104 |
| ProsolParenteral Amino Acid 20% No.1 | 46 | $4,342 |
| Calcium Acetate | 19 | $1,853 |
| Doxazosin Mesylate | 173 | $1,341 |
| Nifedipine ErNifedipine | 40 | $1,298 |
| Minoxidil | 57 | $1,282 |
| Hydralazine Hcl | 89 | $1,116 |
| Amlodipine Besylate | 214 | $1,088 |
| Labetalol Hcl | 23 | $913 |
Paid to pharmacies, not to this prescriber.
Other nephrology in St Louis
- Kevin MartinSt Louis$189K
- Bahar BastaniSt Louis$87K
- Sana ShaikhSt Louis$49K
- Aliza Anwar MemonSt Louis$37K
- Nicholas GourtzelisSt Louis$9K
- Ahmed AwadKansas City$12.4M
- Benjamin HumphreysSaint Louis$1.2M
- Donovan PolackFlorissant$782K
- Derek LarsonCreve Coeur$605K
- Gary SingerSaint Peters$580K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.